Pfizer (PFE)

(Latest | Earliest) View (previous 50) (next 50)

Show WikiData History

Legend: (diff) = difference with preceding revision, (hist) = view history for only this reason, m = minor edit, N = new reason.

(diff)	(hist)			12:16, April 15, 2009	Oharasdaughter (Talk | contribs)	N	(→New Cancer Drug)
(diff)	(hist)			01:53, March 1, 2009	Kishore tce (Talk | contribs)	N	(→Proabability of successis high)
(diff)	(hist)			23:51, January 25, 2009	Bpan (Talk | contribs)	N	(→Wyeth acquisition leads to $4 billion in cost savings)
(diff)	(hist)			10:05, January 15, 2009	Jakeberzon (Talk | contribs)	N	(→Rich dividend is safe and very attractive right now)
(diff)	(hist)			12:33, November 23, 2008	Wshikani (Talk | contribs)		(→Stock is a dirt cheap buy for the value)
(diff)	(hist)			03:09, November 5, 2008	Shiv Kapoor (Talk | contribs)		(→Alpha in Pharma)
(diff)	(hist)			03:07, November 5, 2008	Shiv Kapoor (Talk | contribs)	N	(→Alpha in Pharma)
(diff)	(hist)			12:46, June 23, 2008	Gregfeirman (Talk | contribs)		(→Stock is a dirt cheap buy for the value)
(diff)	(hist)			13:31, June 18, 2008	Bpan (Talk | contribs)	N	(→Stock is a dirt cheap buy for the value)
(diff)	(hist)			19:37, June 16, 2008	Bpan (Talk | contribs)	N	(→7 percent dividend is exceedingly attractive)
(diff)	(hist)			18:16, June 13, 2008	Uraguck (Talk | contribs)	N	(→"Concentration on cardiovascular, arthritis, and diabetes drugs")
(diff)	(hist)			01:46, April 4, 2008	Uraguck (Talk | contribs)	N	(→Restructuring will cut costs by $2 billion)
(diff)	(hist)			01:46, April 4, 2008	Mybikeisgreen4 (Talk | contribs)	N	(→Strong Post-Lipitor Prospects)
(diff)	(hist)			01:46, April 4, 2008	Uraguck (Talk | contribs)	N	(→Pfizer leads the industry in research and development spending)

(Latest | Earliest) View (previous 50) (next 50)

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.